HLB bioStep Company Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 155

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $81.2M

HLB bioStep Company General Information

Description

HLB BioStep Co Ltd provides non-clinical services necessary for leading domestic and foreign pharmaceutical companies and bio ventures in the process of developing drugs and health functional foods.

Contact Information

Website
hlbbiostep.com
Formerly Known As
Knotus
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 38 Academy-ro 79beon-gil
  • Yeonsu-gu
  • Incheon, 22014
  • South Korea
+82
Primary Industry
Biotechnology
Parent Company
Corporate Office
  • 38 Academy-ro 79beon-gil
  • Yeonsu-gu
  • Incheon, 22014
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HLB bioStep Company Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 27-Dec-2021 $81.2M Completed Generating Revenue
2. IPO 27-Nov-2019 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view HLB bioStep Company’s complete valuation and funding history, request access »

HLB bioStep Company Patents

HLB bioStep Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016208961-A1 Pharmaceutical composition for preventing and treating dry eye diseases, containing imatinib as active ingredient Inactive 22-Jun-2015
US-10426769-B2 Pharmaceutical composition for preventing and treating obesity or liver diseases, containg tlr7 agonist Active 01-Jun-2015
US-20180161318-A1 Pharmaceutical composition for preventing and treating obesity or liver diseases, containg tlr7 agonist Active 01-Jun-2015
WO-2016195256-A1 Pharmaceutical composition for preventing and treating obesity or liver diseases, containing tlr7 agonist Inactive 01-Jun-2015 A61K31/4745

HLB bioStep Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLB bioStep Company Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Premier Partners PE/Buyout Minority
ROI Investment Partners Venture Capital Minority
Woori Venture Partners Venture Capital Minority
To view HLB bioStep Company’s complete investors history, request access »

HLB bioStep Company Investments & Acquisitions (8)

HLB bioStep Company’s most recent deal was a Later Stage VC with MediMabBio for . The deal was made on 27-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MediMabBio 27-Oct-2025 Later Stage VC Drug Discovery
Croen 09-May-2024 Merger/Acquisition Biotechnology
Peaklab 01-Sep-2023 Merger/Acquisition Laboratory Services (Healthcare)
HLB Panagene (Biotechnology) 20-Jun-2023 PIPE Biotechnology
Gaebabking 28-Jun-2022 Merger/Acquisition Other Consumer Non-Durables
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

HLB bioStep Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view HLB bioStep Company’s complete esg history, request access »

HLB bioStep Company Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Peaklab Yongin-si, South Korea 2020
Gaebabking Gyeonggi-do, South Korea 2018

HLB bioStep Company FAQs

  • When was HLB bioStep Company founded?

    HLB bioStep Company was founded in 2012.

  • Where is HLB bioStep Company headquartered?

    HLB bioStep Company is headquartered in Incheon, South Korea.

  • What is the size of HLB bioStep Company?

    HLB bioStep Company has 155 total employees.

  • What industry is HLB bioStep Company in?

    HLB bioStep Company’s primary industry is Biotechnology.

  • Is HLB bioStep Company a private or public company?

    HLB bioStep Company is a Private company.

  • What is the current valuation of HLB bioStep Company?

    The current valuation of HLB bioStep Company is .

  • What is HLB bioStep Company’s current revenue?

    The current revenue for HLB bioStep Company is .

  • How much funding has HLB bioStep Company raised over time?

    HLB bioStep Company has raised $8.56M.

  • Who are HLB bioStep Company’s investors?

    Premier Partners, ROI Investment Partners, and Woori Venture Partners have invested in HLB bioStep Company.

  • When was HLB bioStep Company acquired?

    HLB bioStep Company was acquired on 27-Dec-2021.

  • Who acquired HLB bioStep Company?

    HLB bioStep Company was acquired by HLB (Holding Companies).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process